Table 1 Patient and treatment characteristics.

From: Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies

Characteristics

TAM (N = 112)

TAM + OFS (N = 37)

OFS + AI (N = 11)

 

N (%)

N (%)

N (%)

Age (Median [IQR])

43[41–47]

38[34–42]

40[37–46]

BMI (Mean ± SD)

21.95 ± 2.56

22.15 ± 2.72

21.52 ± 2.97

Surgery

Conserving

56 (50)

14 (37.84)

5 (45.45)

Mastectomy

56 (50)

23 (62.16)

6 (54.55)

T (tumor)

T1

81 (72.32)

24 (64.86)

9 (81.82)

T2

25 (22.32)

13 (35.14)

1 (9.09)

T3

3 (2.68)

0

1 (9.09)

Unknown

3 (2.68)

0

0

N (node)

N0

78 (69.64)

17(45.95)

9 (81.82)

N1

31 (27.68)

19(51.35)

2 (18.18)

N2

0

1(2.70)

0

Unknown

3(2.68)

0

0

HER2

+

88(78.57)

33(89.19)

10 (90.91)

24(21.43)

4(10.81)

1 (9.09)

Radiotherapy

Yes

72(64.29)

25(67.57)

10 (90.91)

No

40(35.71)

12(32.43)

1 (9.09)

Chemotherapy

Yes

97(86.61)

37(100)

10(90.91)

No

15(13.39)

0

1 (9.09)